Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for SOPHiA GENETICS SA (SOPH : NSDQ)

• Company Description    SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. SOPHiA GENETICS SA is based in BOSTON. Number of Employees: 423

• Price / Volume Information    Yesterday's Closing Price: $3.12 Daily Weekly Monthly 20 Day Moving Average: 40,583 shares Shares Outstanding: 67.58 (millions) Market Capitalization: $210.85 (millions) Beta: 1.01 52 Week High: $4.92 52 Week Low: $2.58 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -4.88% -6.55% 12 Week 2.63% -6.77% Year To Date 1.63% -6.93%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL LA PIECE CH-1180 - ROLLE,V8 00000 CHE ph: 41-21-694-1060 fax: - None http://www.sophiagenetics.com

• General Corporate Information    Officers Jurgi Camblong - Chief Executive Officer Troy Cox - Chairman Ross Muken - President George Cardoza - Chief Financial Officer Tomer Berkovitz - Director Peer Information SOPHiA GENETICS SA (HLIS) SOPHiA GENETICS SA (AZTA) SOPHiA GENETICS SA (APYI) SOPHiA GENETICS SA (RNVA) SOPHiA GENETICS SA (HMSY) SOPHiA GENETICS SA (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: H82027105 SIC: 7374 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/04/25 Share - Related Items Shares Outstanding: 67.58 Most Recent Split Date: (:1) Beta: 1.01 Market Capitalization: $210.85 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/04/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.75 Price/Cash Flow: - Price / Sales: 3.03 EPS Growth vs. Year Ago Period: 243.48% vs. Previous Quarter: 226.92% Sales Growth vs. Year Ago Period: 15.91% vs. Previous Quarter: 3.06% ROE 06/30/25 - -30.69 03/31/25 - -63.47 12/31/24 - -53.91 ROA 06/30/25 - -17.39 03/31/25 - -40.06 12/31/24 - -36.01 Current Ratio 06/30/25 - 3.39 03/31/25 - 3.11 12/31/24 - 3.71 Quick Ratio 06/30/25 - 3.21 03/31/25 - 2.94 12/31/24 - 3.49 Operating Margin 06/30/25 - -40.99 03/31/25 - -98.51 12/31/24 - -95.89 Net Margin 06/30/25 - -40.99 03/31/25 - -98.51 12/31/24 - -95.89 Pre-Tax Margin 06/30/25 - -102.43 03/31/25 - -96.41 12/31/24 - -94.01 Book Value 06/30/25 - 1.13 03/31/25 - 1.28 12/31/24 - 1.48 Inventory Turnover 06/30/25 - 3.80 03/31/25 - 3.58 12/31/24 - 3.41 Debt-to-Equity 06/30/25 - 0.62 03/31/25 - 0.16 12/31/24 - 0.14 Debt-to-Capital 06/30/25 - 38.23 03/31/25 - 13.46 12/31/24 - 12.06

Powered by Zacks Investment Research ©